Table 5.
Summary of patients with intracranial SFTs/HPCs and liver metastases.
| Number | Year of Publication | Author | Age #/Sex | Time to Metastasis (Years) | Other Sites of Metastatic Disease | Treatment (for Liver Metastases) |
Outcome (Follow-Up in Months) * |
|---|---|---|---|---|---|---|---|
| 1 | 1959 | Meredith [44] | 44/F | 13 | Bone, Kidney, Pancreas, Mediastinum, Lung | None | DOD (N/A) |
| 2 | 1960 | Hukill and Lowman [45] | 43/F | 11 | None | Surgical resection | DOD (2) |
| 3 | 1971 | Petito and Porro [46] | 76/F | 11 | None | N/A (autopsy finding) | Died due to duodenal perforation following brain surgery |
| 4 | 1976 | Jestico et al. [47] | 47/M | 6 | Kidney, Pancreas, Lymph nodes | N/A | N/A |
| 5 | 1984 | Itoh et al. [48] | 49/M | 6 | Bone | N/A | N/A |
| 6 | 1988 | Yoshida et al. [49] | 33/M | 6 | None | Surgical resection | AWD (31) |
| 7 | 1991 | Chakravarty et al. [50] | 41/F | 6 | None | Surgical resection | NED (7) |
| 8 | 1993 | Kaneko et al. [51] | 54/M | 19 | None | Surgical resection | NED (9) |
| 9 | 1996 | Sohda et al. [31] | 64/F | 20 | None | TAE | Died due to massive liver hemorrhage following TACE |
| 10 | 1998 | Niwa et al. [52] | 55/M | 13 | Lung, Bone, Pancreas | Surgical resection, Radiotherapy | AWD (84) |
| 11 | 1999 | Grunenberger et al. [38] | 42/F | 12 | Lung, Bone | Chemotherapy, TACE, Surgical resection |
NED (31) |
| 12 | 2001 | Someya et al. [53] | 56/F | 14 | Bone, Lung | None | DOD (6) |
| 13 | 2004 | Spatola and Privitera [54] | 48/F | 10 | Kidney, Breast | Surgical resection, Chemotherapy |
DOD (27) |
| 14 | 2004 | Kim et al. [55] | 62/M | 7 | Bone, Lung | None | AWD (24) |
| 15 | 2004 | Chang et al. [56] | 48/F | 5 | Bone, Lung, Kidney | N/A | N/A |
| 16 | 2004 | Miyamoto et al. [57] | 61/F | N/A | Bone | N/A | N/A |
| 17 | 2009 | Iwamuro et al. [58] | 54/F | 10 | Bone | RFA, TACE | NED (60) |
| 18 | 2010 | Chan et al. [59] | 49/F | 7 | Lung | Chemotherapy | N/A |
| 19 | 2012 | Chan et al. [28] | 50/M | 7 | Kidney, Bone, Abdominal cavity, | Chemotherapy | AWD (N/A) |
| 20 | 2014 | Lee et al. [60] | 60/M | 8 | Pancreas, Lung, Bone | Surgical resection, RFA, Chemotherapy | AWD (~24) |
| 21 | 2015 | De Martin et al. [61] | 48/F | 4 | Bone | Liver transplant | NED (60) |
| 22 | 2015 | Nickerson et al. [62] | 65/M | 25 | Abdominal cavity, Bone | Chemotherapy | AWD (~36) |
| 23 | 2015 | Manatakis et al. [63] | 35/M | 12 | Bone | Surgical resection, RFA, TAE | AWD (12) |
| 24 | 2015 | Urata et al. [64] | 58/M | 16 | Bone, Lung, Soft tissue | TACE, LDLT | DOD (65) |
| 25 | 2016 | Han et al. [65] | 42/F | 18 | None | N/A | AWD (N/A) |
| 26 | 2016 | Han et al. [65] | 36/M | 6 | Lung, Bone, Spinal cord | N/A | DOD (N/A) |
| 27 | 2016 | Han et al. [65] | 53/F | 10 | Breast, Lung | N/A | AWD (N/A) |
| 28 | 2016 | Lo et al. [66] | 35/M | 5 | N/A | Chemotherapy | AWD (34) |
| 29 | 2016 | Lo et al. [66] | 51/F | 19 | N/A | Surgical resection | NED (26) |
| 30 | 2016 | Lo et al. [66] | 60/M | 16 | N/A | Surgical resection | NED (39) |
| 31 | 2016 | Lo et al. [66] | 31/F | 7 | N/A | Surgical resection, RFA | AWD (36) |
| 32 | 2016 | Lo et al. [66] | 48/M | 12 | N/A | RFA | DOD (36) |
| 33 | 2018 | Patro et al. [67] | 53/F | N/A | Bone | Chemotherapy | N/A |
| 34 | 2019 | Reddy et al. [17] | 74/M | 0 | None | SBRT, Chemotherapy |
AWD (18) |
| 35 | 2020 | Hasimu et al. [18] | 62/F | 6 | None | Surgical resection | NED (6) |
| 36 | 2020 | Maeda et al. [68] | 52/F | 13 | Lung | Surgical resection, Systemic therapy |
DOD (59) |
| 37 | 2021 | Maeda et al. [30] | 49/M | 10 | Lung, Kidney, Adrenal gland, Abdominal Cavity | N/A | DOD (0) |
| 38 | 2022 | Krendl et al. | 67/F | 8 | Abdominal cavity | SRFA | NED (39) |
| 39 | 2022 | Krendl et al. | 39/F | 8 | None | TAE, Surgical resection, SRFA | AWD (73) |
| 40 | 2022 | Krendl et al. | 65/F | 15 | Bone, Abdominal cavity | TAE, Surgical resection, SRFA | DOD (89) |
# Age recorded at diagnosis of liver metastases; * Duration from diagnosis of hepatic metastasis to last follow-up or death; AWD, alive with disease; DOD, died of disease; LDLT, living donor liver transplantation; N/A, not available; NED, no evidence of disease; RFA, radiofrequency ablation; SBRT, stereotactic body radiation therapy; SRFA, stereotactic radiofrequency ablation; TACE, transarterial chemoembolization; TAE, transarterial mechanical embolization.